metformin has been researched along with Leishmaniasis, American in 1 studies
Metformin: A biguanide hypoglycemic agent used in the treatment of non-insulin-dependent diabetes mellitus not responding to dietary modification. Metformin improves glycemic control by improving insulin sensitivity and decreasing intestinal absorption of glucose. (From Martindale, The Extra Pharmacopoeia, 30th ed, p289)
metformin : A member of the class of guanidines that is biguanide the carrying two methyl substituents at position 1.
Excerpt | Relevance | Reference |
---|---|---|
"Metformin (MET) is a hypoglycemic drug used for the treatment of diabetes, despite interference in host immunity against microorganisms." | 1.56 | Metformin promotes susceptibility to experimental Leishmania braziliensis infection. ( Arruda, S; Bonyek-Silva, I; Carvalho Filho, EM; Ferreira, LM; Lima, FR; Malta, TA; Santos, RL; Tavares, NM, 2020) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 1 (100.00) | 2.80 |
Authors | Studies |
---|---|
Lima, FR | 1 |
Ferreira, LM | 1 |
Malta, TA | 1 |
Bonyek-Silva, I | 1 |
Santos, RL | 1 |
Tavares, NM | 1 |
Carvalho Filho, EM | 1 |
Arruda, S | 1 |
1 other study available for metformin and Leishmaniasis, American
Article | Year |
---|---|
Metformin promotes susceptibility to experimental Leishmania braziliensis infection.
Topics: Animals; Brazil; Leishmania; Leishmania braziliensis; Leishmaniasis, Cutaneous; Metformin; Mice; Mic | 2020 |